Adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules

base) 1mg/1ml (1 in 1,000) solution for injection ampoules (advanz pharma - adrenaline acid tartrate - solution for injection - 1mg/1ml

Adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules

base) 1mg/1ml (1 in 1,000) solution for injection ampoules (hameln pharma ltd - adrenaline acid tartrate - solution for injection - 1mg/1ml

Dormicum ® 5mg/1ml Injection United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

dormicum ® 5mg/1ml injection

lunatus drug store llc france - 1ml ampoule x 10's - injection - 5mg/1ml - central nervous system-hypnotics , anxiolytics

SIGNIFOR pasireotide 900 microgram/1 mL (as diaspartate) solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 900 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 1128.6 microgram (equivalent: pasireotide, qty 900 microgram) - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; tartaric acid - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 300 microgram/1 mL (as diaspartate) solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 300 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 376.2 microgram (equivalent: pasireotide, qty microgram) - injection, solution - excipient ingredients: water for injections; mannitol; tartaric acid; sodium hydroxide - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 600 microgram/1 mL (as diaspartate) solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 600 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 752.4 microgram (equivalent: pasireotide, qty 600 microgram) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; tartaric acid; mannitol - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

Adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules

base) 1mg/1ml (1 in 1,000) solution for injection ampoules (a a h pharmaceuticals ltd - adrenaline acid tartrate - solution for injection - 1mg/1ml

Adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules

base) 1mg/1ml (1 in 1,000) solution for injection ampoules (martindale pharmaceuticals ltd - adrenaline acid tartrate - solution for injection - 1mg/1ml

Adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

adrenaline (base) 1mg/1ml (1 in 1,000) solution for injection ampoules

base) 1mg/1ml (1 in 1,000) solution for injection ampoules (alliance healthcare (distribution) ltd - adrenaline acid tartrate - solution for injection - 1mg/1ml